SCHEMBL5129463

SCHEMBL5129463

COCCOc1cc(CC(=O)O)cc(Oc2cccc(-c3ccccc3OC)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 6/20 0.47
FFAR4 Q5NUL3 2/20 0.46
THRA P10827 2/20 0.46
THRB P10828 2/20 0.46
PTGER4 P35408 2/20 0.43
CTSA P10619 1/20 0.43
PTGER1 P34995 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTPN5 P54829 1/20 0.42
ICMT O60725 1/20 0.41
SELL P14151 1/20 0.40
SELP P16109 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5126065 0.92 FFAR1 (0.47) FFAR1FFAR4THRATHRBPTGER4
SCHEMBL5122669 0.90 FFAR1 (0.48) FFAR1FFAR4THRATHRBPTGER4
SCHEMBL5129129 0.86 FFAR1 (0.46) FFAR1FFAR4THRATHRBPTGER4
SCHEMBL5122484 0.85 NR1H2 (0.46) FFAR1FFAR4THRATHRBNR1H4
SCHEMBL5123906 0.84 FFAR1 (0.62) FFAR1FFAR4THRATHRBPTGER4
SCHEMBL5132456 0.84 FFAR1 (0.49) FFAR1FFAR4THRATHRBPTGER2
SCHEMBL5132200 0.82 FFAR1 (0.48) FFAR1PTGER4CTSAPTGER1PTGER3
SCHEMBL5129447 0.81 FFAR4 (0.53) FFAR1FFAR4THRATHRB
SCHEMBL5131820 0.81 PPARD (0.44) FFAR1FFAR4THRATHRBCTSA
SCHEMBL5123879 0.80 FFAR1 (0.57) FFAR1FFAR4THRATHRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249137-A1 PPAR active compounds PPARG, PPARA, PPARD FFAR1 57/4885FFAR4 60/4885THRA 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.